Product logins

Find logins to all Clarivate products below.


Jasmin Mehta

Senior Manager, Centre for Medicines Research

Jasmin Mehta is a Senior Manager within the Life Science Professional Services team at Clarivate. She has over 19 years of experience within Pharmaceutical R&D analytics and currently leads a broad array of assignments including Pharma R&D industry benchmarking, competitive landscape analysis and building business intelligence platforms within the R&D development space. She has extensive experience working with the business intelligence teams of leading pharmaceutical companies on topics such as R&D productivity , portfolio risk and protocol complexity. Prior to joining Clarivate, she has held a consulting role within the market research and data analytics team of a strategy consulting firm. ​

Jasmin has a Masters degree in Corporate Governance from Kingston University, London and a Bachelors degree in Economics and English Literature from the University of Mumbai.​


arrow_forward
Get in touch with Jasmin

Latest news

News July 20, 2026
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers

Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals London, U.K. July, 20, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today…

News July 16, 2026
USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate

London, U.K. July, 16, 2026. Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, is proud to support the U.S. Patent and Trademark Office (USPTO) in launching an AI…

News July 14, 2026
Clarivate Selected by Abes to Modernize French National Academic Library System

New cloud-based, shared and scalable platform based on Alma, Primo and Rapido creates a unified library experience Library services, resource sharing and AI-powered discovery in one platform London, U.K. July…

Related resources

Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
Blog June 24, 2026
Bringing oncology medicines to patients faster: How Clarivate R&D Consulting supports every step to approval
ADC Biopharma Biotech Bispecific antibodies BsAb Clinical trials Development Oncology Pharma R&D Regulatory Research
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Blog June 22, 2026
Using AI-powered translational safety intelligence to anticipate drug safety issues earlier
Biopharma Biotech Clinical trials CMC Development R&D Real-World Data Regulatory Research Safety
Three uncomfortable truths about cell and gene therapy in regulatory affairs Three uncomfortable truths about cell and gene therapy in regulatory affairs
Blog May 28, 2026
Three uncomfortable truths about cell and gene therapy in regulatory affairs
Consulting Resource Center Regulatory
How the Inflation Reduction Act could impact access to more convenient therapeutics How the Inflation Reduction Act could impact access to more convenient therapeutics
Blog February 17, 2026
How the Inflation Reduction Act could impact access to more convenient therapeutics
Biopharma Biotech Commercialization Consulting Resource Center FDA HMO Insurance Launch Managed care Market Access North America Payer Pharma pricing Route of administration U.S.